Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.01194-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Emily Puumala und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Antifungal Agents, Zinc, Administration, Topical, Microbial Sensitivity Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, HHS | NIH | National Cancer Institute (NCI), HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
Fungal disease affects over a billion people worldwide. Naamidine A inhibits the growth of diverse fungal pathogens through an unknown mechanism. Here, we show that the supplementation of medium with excess zinc abolishes the antifungal activity of naamidine A. Furthermore, we highlight that naamidine A has in vitro activity against terbinafine-resistant Trichophyton spp . and in vivo efficacy in a mouse model of dermatomycosis caused by T. mentagrophytes, highlighting its therapeutic potential as a topical treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
- Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.
- Natural Products Support Group, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
- Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland, USA.
- Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
- David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Emily Puumala, Priya Uppuluri, Leah E Cowen
Förderung
- Intramural NIH HHS
- HHS | NIH | National Cancer Institute (NCI)
- HHS | National Institutes of Health (NIH)
- CCR NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- Canadian Government | Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Puumala, E., Nabeela, S., Thornburg, C. C., Grkovic, T., Uppuluri, P., Whitesell, L., O'Keefe, B. R., Robbins, N., & Cowen, L. E. (2024). Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01194-24
Vancouver
Puumala E, Nabeela S, Thornburg CC, Grkovic T, Uppuluri P, Whitesell L, et al. Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01194-24
BibTeX
@article{Puumala2024,
author = {Puumala, Emily and Nabeela, Sunna and Thornburg, Christopher C and Grkovic, Tanja and Uppuluri, Priya and Whitesell, Luke and O'Keefe, Barry R and Robbins, Nicole and Cowen, Leah E},
title = {Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.01194-24}
}
EUVIMED